An astronaut in need of medical care is on the way back to Earth, NASA's first medical evacuation from space. The ailing ...

A study of female U.S. service members found that getting a COVID-19 vaccine before or during pregnancy didn't raise the risk ...

In late 2025, Arcturus Therapeutics Holdings Inc. filed an omnibus shelf registration of up to US$500 million, covering ...

In a new study, we and an international team scientists examined the behavior of marine viruses in a large band of ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Plastic trash lining a mountain trail might not seem like the start of a chemistry breakthrough, but for Yuwei Gu, it was.

Korro is a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases. Korro is generating a portfolio of ...

A profound transformation is taking place in therapeutic discovery, development, and delivery.2026 will be a pivotal year for biopharma. From digital transformation to an AI revolution to more ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...

While HDFC Securities has assigned a 'Buy' rating to Divi's Labs, Sai Life Sciences, and Piramal Pharma, it has given an 'Add ...